IRIS
COLECCHIA, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.949
EU - Europa 3.513
NA - Nord America 2.824
SA - Sud America 1.105
Continente sconosciuto - Info sul continente non disponibili 374
AF - Africa 76
OC - Oceania 4
Totale 11.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.642
RU - Federazione Russa 2.121
SG - Singapore 1.307
CN - Cina 1.271
BR - Brasile 919
HK - Hong Kong 602
IT - Italia 442
VN - Vietnam 365
SE - Svezia 334
FR - Francia 179
DE - Germania 123
BD - Bangladesh 117
CA - Canada 74
GB - Regno Unito 72
AR - Argentina 66
IN - India 62
FI - Finlandia 57
MX - Messico 53
EC - Ecuador 43
AT - Austria 41
ID - Indonesia 34
IQ - Iraq 34
ES - Italia 27
PL - Polonia 26
TR - Turchia 25
ZA - Sudafrica 25
CO - Colombia 22
JP - Giappone 21
NL - Olanda 21
VE - Venezuela 17
PK - Pakistan 15
UZ - Uzbekistan 14
UA - Ucraina 12
CR - Costa Rica 11
PY - Paraguay 11
SA - Arabia Saudita 11
TN - Tunisia 11
CL - Cile 10
JO - Giordania 10
KE - Kenya 10
JM - Giamaica 9
PE - Perù 9
RO - Romania 9
AE - Emirati Arabi Uniti 8
IE - Irlanda 8
LT - Lituania 7
MA - Marocco 7
MY - Malesia 7
NI - Nicaragua 7
NP - Nepal 7
PT - Portogallo 7
AL - Albania 6
PH - Filippine 6
SN - Senegal 6
EG - Egitto 5
UY - Uruguay 5
BG - Bulgaria 4
GR - Grecia 4
GT - Guatemala 4
KZ - Kazakistan 4
PA - Panama 4
PR - Porto Rico 4
AU - Australia 3
BB - Barbados 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KR - Corea 3
OM - Oman 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
LV - Lettonia 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
NG - Nigeria 1
Totale 11.465
Salva come PNG Salva come JPEG
Città #
Hong Kong 599
Singapore 577
Moscow 504
San Jose 293
Dallas 292
Shanghai 290
Ashburn 275
Council Bluffs 240
Hefei 180
Beijing 159
Ho Chi Minh City 154
Lauterbourg 153
Lawrence 149
Princeton 149
New York 133
Milan 124
Los Angeles 75
São Paulo 75
Hanoi 69
Santa Clara 58
Boardman 45
Rio de Janeiro 45
Helsinki 39
Nuremberg 39
Rome 31
Guangzhou 29
Brasília 26
Chicago 26
Atlanta 22
Porto Alegre 21
Orem 20
Phoenix 20
Belo Horizonte 19
Warsaw 19
Chennai 18
Montreal 18
Da Nang 17
Houston 17
Munich 17
Baghdad 16
Frankfurt am Main 16
Naples 16
Curitiba 14
Dhaka 14
Guayaquil 14
Shenzhen 14
Denver 13
Johannesburg 13
London 13
Manchester 13
Salvador 13
Brooklyn 12
Haiphong 12
Lappeenranta 12
Mexico City 12
Tashkent 12
Tokyo 12
Turin 12
Buffalo 11
Quito 11
Toronto 11
Vienna 11
Amman 10
Ankara 10
Catania 10
Goiânia 10
Mumbai 10
Osasco 10
Poplar 10
Rozzano 10
Fortaleza 9
Guarulhos 9
Juiz de Fora 9
Nairobi 9
San Francisco 9
Stockholm 9
Thái Bình 9
Boston 8
Buenos Aires 8
Caxias do Sul 8
Dublin 8
Erbil 8
Jakarta 8
Jiaxing 8
Miami 8
Nova Iguaçu 8
Querétaro 8
San José 8
The Dalles 8
Thái Nguyên 8
Tianjin 8
Washington 8
Bogotá 7
Brescia 7
Can Tho 7
Cesano Boscone 7
Changsha 7
Charlotte 7
Cluj-Napoca 7
Genoa 7
Totale 5.652
Salva come PNG Salva come JPEG
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 236
Role of Follicle-stimulating Hormone, Inhibin B, and Anti-Müllerian Hormone in Predicting Sperm Retrieval from Men with Nonobstructive Azoospermia Undergoing Microdissection Testicular Sperm Extraction: A Systematic Review and Meta-analysis 167
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 163
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 136
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 135
A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings 133
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 126
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 120
Anti-Müllerian hormone predicts positive sperm retrieval in men with idiopathic non-obstructive azoospermia-findings from a multi-centric cross-sectional study 119
Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration 118
A case report of myoid gonadal stromal tumor treated with testis sparing surgery 113
Total embedding of spermatic cord and hilar soft tissue in orchiectomy for seminoma: does the extensive sampling improve pathologic risk factors? 113
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 112
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 111
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study) 109
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 109
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 107
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 105
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 102
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer 102
[The treatment of early-stage germ cell tumors of the testis (GCTT)]. [Il trattamento dei Tumori Germinali del Testicolo (TGT) in fase iniziale.] 101
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 99
H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma 97
Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature 97
A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature. 97
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient 91
Sex cord stromal tumors and tumors of the paratestis: new and old entities in a landscape of rare tumors 90
Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty 87
Immunohistochemistry to Enhance Prognostic Allocation and Guide Decision-Making of Patients With Advanced Urothelial Cancer Receiving First-Line Chemotherapy 87
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 85
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 84
CD 57 Antigen 82
The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer 81
SOX2 and PRAME in the “reprogramming” of seminoma cells 80
Carney triad: case report and molecular analysis of gastric tumor 79
Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure 77
Penile cancer 77
Benign glomus tumor of the urinary bladder. 77
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis 76
Carcinoma tiroideo iperfunzionante.Descrizione di un caso. 74
Myoid gonadal tumor. Case series, systematic review, and Bayesian analysis 74
Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma 73
Assessment and reporting of pathological findings of penile specimens 73
Pathology of testicular and penile neoplasms 73
Large cell calcifying Sertoli cell tumour: molecular and immunohistochemical assessment of a series comprising non-metastasising and metastasising neoplasms 72
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System 72
Mediastinal germ cell tumors: A narrative review of their traits and aggressiveness features 70
Teratoma With Somatic-Type Malignant Components in Germ Cell Tumors of the Testis: A Clinicopathologic Analysis of 40 Cases With Outcome Correlation 70
The Leydig cell tumour Scaled Score (LeSS): a method to distinguish benign from malignant cases, with additional correlation with MDM2 and CDK4 amplification 70
News in the classification of WHO 2022 testicular tumours 70
FoxA2 is a reliable marker for the diagnosis of yolk sac tumour postpubertal-type 68
Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): An open-label, single-arm, phase II study 68
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer 67
Dual modulation of MCL-1 and mTOR determines the response to sunitinib 66
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT 65
Renal tumor biopsy in patients with cT1b-T4-M0 disease susceptible to radical nephrectomy: analysis of safety, accuracy and clinical impact on definitive management 65
Clinical Outcome in Testicular Sex Cord Stromal Tumors: Testis Sparing vs Radical Orchiectomy and Management of Advanced Disease 65
Understanding the somatic-type malignant differentiation in male germ-cell cancer: A work in progress. Response to the article by Spiess et al., Malignant transformation of testicular teratoma: A chemoresistant phenotype. Urol Oncol 2008;26:595-9 65
The Relationship between Characteristics of Inguinal Lymph Nodes and Pelvic Lymph Node Involvement in Penile Squamous Cell Carcinoma: A Single Institution Experience 65
Association of Androgen Receptor Expression on Tumor Cells and PD-L1 Expression in Muscle-Invasive and Metastatic Urothelial Carcinoma: Insights for Clinical Research 65
Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients 63
Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment 63
Salivary duct carcinoma of the parotid gland. Report of a case with cytologic and Immunocytochemical findings on fine needle aspiration biopsy 63
Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal 63
Detection Rate of Anterior Prostate Cancer in 226 Patients Submitted to Initial and Repeat Transperineal Biopsy 62
Frequent mutation and nuclear localization of β-catenin in sertoli cell tumors of the testis 62
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists 61
Yolk sac tumor of postpubertal-type does not exhibit immunohistochemical loss of SMARCB1/INI1 and SMARCA4/BRG1…but choriocarcinoma? 60
Relationship between lymph node ratio and cancer-specific survival in a contemporary series of patients with penile cancer and lymph node metastases 60
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism 60
Integrative transcriptomic analysis reveals distinctive molecular traits and novel subtypes of collecting duct carcinoma 60
Genomic analysis of spermatocytic tumors demonstrates recurrent molecular alterations in cases with malignant clinical behavior 60
TAMs PD-L1(+) in the reprogramming of germ cell tumors of the testis 59
Treatment of Carcinoma In Situ of the Glans Penis With Topical Imiquimod Followed by Carbon Dioxide Laser Excision 59
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases 59
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 58
Prostatic and urothelial metastasis in the same lymph node: a case report 58
Myomelanocytic tumor of the thigh 58
Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma 58
Prediction of grade reclassification of prostate cancer patients on active surveillance through the combination of a three-mirna signature and selected clinical variables 58
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure 57
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment 57
Malaric placentas A quantitative study and clinicopathological correlations 57
How do endoscopic bladder tumor resection techniques affect pathology practice? EAU Section of Uro-Technology (ESUT) and Uropathology (ESUP) survey 56
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 56
Clinical Outcomes in Clinical N0 Squamous Cell Carcinoma of the Penis According to Nodal Management: Early, Delayed or Selective (following Dynamic Sentinel Node Biopsy) Inguinal Lymph-Node Dissection 56
Myoid gonadal stromal tumours are characterised by recurrent chromosome-level copy number gains: molecular assessment of a multi-institutional series 55
Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study 55
Concordance and Prediction Ability of Original and Reviewed Vascular Invasion and Other Prognostic Parameters of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors After Retroperitoneal Lymph Node Dissection 55
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 55
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors 55
Immunophenotypic and genotypic analysis of a case of primary peripheral primitive neuroectodermal tumour (pPNET) of the urinary bladder 55
New Italian guidelines on bladder cancer, based on the World Health Organization 2004 classification 55
The contributions of Juan Rosai to testicular pathology with personal remembrances 55
Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed 54
Prognostic Effect of FGFR Mutations or Gene Fusions in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Results from a Large, Single-institution Cohort 53
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon 53
Imatinib mesylate in chordoma 53
pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy 53
Erratum to 'Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations'[European Urology Oncology 2 (2019) 277-285 52
Totale 7.931
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022100 0 5 2 29 6 2 28 6 3 1 5 13
2022/2023696 348 149 37 4 1 89 11 32 10 6 5 4
2023/2024494 13 27 30 154 21 74 44 35 7 22 15 52
2024/20252.597 394 32 70 44 109 193 279 224 473 444 166 169
2025/20267.052 542 499 561 1.058 432 205 571 438 1.915 357 258 216
2026/2027766 352 414 0 0 0 0 0 0 0 0 0 0
Totale 11.845